US 8664193
Compositions and methods for inhibiting expression of factor VII gene
granted A61PA61P29/00A61P31/12
Quick answer
US patent 8664193 (Compositions and methods for inhibiting expression of factor VII gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P29/00, A61P31/12, A61P43/00, A61P7/04